http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115201494-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6f10c42037f0c11736eb81a6a6076f7 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-325 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate | 2022-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99879534970ef018c1944d1c836e63a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eabc2445b7759688296c7d8ce023289e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9ff4650fe160906684577023cfe433f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13c4730aaa9c1bff82783c6c9e79a252 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59a84bfd4f96cadb92a19f23d2263970 |
| publicationDate | 2022-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-115201494-A |
| titleOfInvention | Application of secreted frizzled-related protein 1 in preparation and diagnosis of primary dilated cardiomyopathy |
| abstract | The invention provides the application of secreted frizzled-related protein 1 in the preparation and diagnosis of primary dilated cardiomyopathy. The secreted frizzled-related protein 1 can not only be used in the preparation and diagnosis of primary dilated cardiomyopathy, but also The invention is used in a kit for diagnosing primary dilated cardiomyopathy. The kit is prepared for diagnosing, evaluating and prognosing primary dilated cardiomyopathy, and the detection sample of the kit is venous blood; the present invention proposes for the first time secretory crimp Related protein 1 is used to diagnose human primary dilated cardiomyopathy, screen out the gene with the most significant difference in cardiac tissue expression in patients with dilated cardiomyopathy, and verify the expression difference of this protein in the serum of patients, as well as severity assessment and prognosis judgment. To help early risk stratification of patients with dilated cardiomyopathy, so as to achieve early specific treatment and improve the survival rate of patients. |
| priorityDate | 2022-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.